Observations placeholder
Frova
Identifier
019078
Type of Spiritual Experience
Number of hallucinations: 7
Background
A description of the experience
Frovatriptan (trade name Frova) is a triptan drug for the treatment of migraine headaches and for short term prevention of menstrual migraine.
Pharmacology
Frovatriptan inhibits excessive dilation of arteries that supply blood to the head. It is available as 2.5 mg tablets.
Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than other triptans.
Adverse effects
Serious cardiac events have been reported in patients with risk factors predictive of CAD. These include: coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia and ventricular fibrillation.
On Jan, 05, 2017 824 people reported to have side effects when taking Frova.
Among them, 7 people (0.85%) have Hallucination